杵针联合体外冲击波疗法对脑卒中患者上肢痉挛状态的疗效研究

注册号:

Registration number:

ChiCTR2300077318 

最近更新日期:

Date of Last Refreshed on:

2024-05-23 21:28:32 

注册时间:

Date of Registration:

2023-11-06 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

杵针联合体外冲击波疗法对脑卒中患者上肢痉挛状态的疗效研究

Public title:

The effects of extracorporeal shock wave therapy and Pestle needle therapy in post-stroke patients with arm spasticity

注册题目简写:

English Acronym:

研究课题的正式科学名称:

杵针联合体外冲击波疗法对脑卒中患者上肢痉挛状态的疗效研究

Scientific title:

The effects of extracorporeal shock wave therapy and Pestle needle therapy in post-stroke patients with arm spasticity

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

甄丽君 

研究负责人:

甄丽君 

Applicant:

Lijun Zhen 

Study leader:

Lijun Zhen 

申请注册联系人电话:

Applicant telephone:

+86 177 0162 8436

研究负责人电话:

Study leader's
telephone:

+86 177 0162 8436

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zlj15153149@163.com

研究负责人电子邮件:

Study leader's E-mail:

zlj15153149@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区淮海中路966号

研究负责人通讯地址:

上海市徐汇区淮海中路966号

Applicant address:

966 Huaihai Middle Road, Xuhui District, Shanghai, China

Study leader's address:

966 Huaihai Middle Road, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市徐汇区中心医院康复科

Applicant's institution:

Department of Rehabilitation Medicine, Shanghai Xuhui Central Hospital

研究负责人所在单位:

上海市徐汇区中心医院康复科

Affiliation of the Leader:

Department of Rehabilitation Medicine, Shanghai Xuhui Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2022)科审第(058)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市徐汇区中心医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Xuhui Central Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-01-11 00:00:00

伦理委员会联系人:

欧美贤

Contact Name of the ethic committee:

Meixian Ou

伦理委员会联系地址:

上海市徐汇区淮海中路966号

Contact Address of the ethic committee:

966 Huaihai Middle Road, Xuhui District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 5404 3676

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市徐汇区中心医院康复科

Primary sponsor:

Department of Rehabilitation Medicine, Shanghai Xuhui Central Hospital

研究实施负责(组长)单位地址:

上海市徐汇区淮海中路966号

Primary sponsor's address:

966 Huaihai Middle Road, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市徐汇区中心医院

具体地址:

上海市徐汇区淮海中路966号

Institution
hospital:

Shanghai Xuhui Central Hospital

Address:

966 Huaihai Middle Road, Xuhui District, Shanghai, China

经费或物资来源:

上海市徐汇区中心医院

Source(s) of funding:

Shanghai Xuhui Central Hospital

研究疾病:

痉挛状态  

Target disease:

Spasticity

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

从行为学、生物力学、神经电生理学方面观察杵针对脑卒中后肢体痉挛状态的治疗效果,并比较杵针、冲击波治疗对脑卒中后肢体痉挛状态的疗效,为脑卒中后肢体痉挛状态治疗提供新的方法。  

Objectives of Study:

To analyse the effects of extracorporeal shock wave therapy and Pestle needle therapy in post-stroke patients with arm spasticity, we want to compare the effect of different treatment methods on the upper limb spasticity in post-stroke ptients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.既往存在帕金森病等可致高肌张力疾病的患者; 2.存在严重视力、听力、言语、认知障碍或精神障碍等不能配合检查者; 3.非首次发生脑卒中或既往发生过腔隙性脑梗死且存在后遗症的患者; 4.所测关节本身存在疾患(例如疼痛、严重感染、关节手术、风湿或类风湿性关节炎)限制关节活动; 5.皮肤存在影响检查的破损,对电极贴片过敏者或破损,不能耐受肌电图检查者; 6.正在参加影响本研究结果评价的其他临床试验者。

Exclusion criteria:

1. Patients who have Parkinson's disease and other high muscle tone; 2. Patients who have serious cognitive, verbal, visual, hearing or mental disorders and other effects of examination and treatment; 3. Patients who had a lacunar infarction and have sequelae; 4. Patients who have joint with disease (such as joint surgery or rheumatoid arthritis); 5. There are contraindications for surface electromyography or transcutaneous electrical nerve stimulation (such as epidermal damage, fever, etc.); 6. Participating in other clinical trials.

研究实施时间:

Study execute time:

From 2023-11-06 00:00:00 To 2025-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-11-06 00:00:00 To 2025-10-31 00:00:00

干预措施:

Interventions:

组别:

治疗A组

样本量:

15

Group:

A Group

Sample size:

干预措施:

常规康复+杵针

干预措施代码:

Intervention:

conventional rehabilitation and Pestle needle

Intervention code:

组别:

治疗B组

样本量:

15

Group:

B Group

Sample size:

干预措施:

常规康复+体外冲击波治疗

干预措施代码:

Intervention:

conventional rehabilitation and extracorporeal shock wave therapy

Intervention code:

组别:

治疗C组

样本量:

15

Group:

C Group

Sample size:

干预措施:

常规康复+杵针+体外冲击波治疗

干预措施代码:

Intervention:

conventional rehabilitation+Pestle needle

Intervention code:

组别:

对照组

样本量:

15

Group:

control Group

Sample size:

干预措施:

常规康复

干预措施代码:

Intervention:

conventional rehabilitation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市徐汇区中心医院 

单位级别:

三级 

Institution
hospital:

Shanghai Xuhui Central Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

改良Ashworth评分

指标类型:

主要指标

Outcome:

modified Ashworth scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

三倍痉挛状态量表

指标类型:

主要指标

Outcome:

triple spasticity scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

频率

指标类型:

次要指标

Outcome:

Frequency

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

H 反射

指标类型:

次要指标

Outcome:

H reflex

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中枢传导时间

指标类型:

附加指标

Outcome:

central motor conduction time

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

NA

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

受试者根据入组顺序,按照数字表法进行简单随机分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Random digital table method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Resman 数据库平台上传试验数据。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Uploading test data on Resman database platform.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-11-06 09:06:27